EFFECTS OF NALOXONE ON THE HORMONAL RESPONSE TO ECT

EFFECTS OF NALOXONE ON THE HORMONAL RESPONSE TO ECT

Bibliographic Details
Main Authors:	Turner, T, Ur, E, Grossman, A
Format:	Journal article
Published:	1987

Similar Items

Naloxone has no effect on hormonal responses to ECT in man.
by: Turner, T, et al.
Published: (1987)

NALOXONE AND ECT-INDUCED PROLACTIN-RELEASE - REPLY
by: Grossman, A
Published: (1988)

Effect of sodium valproate on luteinizing hormone secretion in pre- and postmenopausal women and its modulation by naloxone infusion.
by: Popovic, V, et al.
Published: (1996)

Enhancement of the sympathoadrenal response to the cold-pressor test by naloxone in man.
by: Bouloux, P, et al.
Published: (1985)

NALOXONE PROVOKES CATECHOLAMINE RELEASE IN PHEOCHROMOCYTOMAS
by: Bouloux, P, et al.
Published: (1985)

The effect of naloxone on pulsatile gonadotrophin release in normal subjects.
by: Moult, P, et al.
Published: (1981)

Differential effect of high-dose naloxone on the plasma adrenaline response to the cold-pressor test.
by: Bouloux, P, et al.
Published: (1989)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
by: Bouloux, P, et al.
Published: (1986)

EFFECT OF 12-HOUR INFUSION OF NALOXONE ON MOOD AND COGNITION IN NORMAL-MALE VOLUNTEERS
by: Delcampo, A, et al.
Published: (1992)

Effect of electrode placement on speed of response to ECT
by: D. Mcloughlin, et al.
Published: (2021-04-01)

High-dose naloxone modifies cardiovascular and neuroendocrine function in ambulant subjects.
by: McMurray, R, et al.
Published: (1991)

NALOXONE INFUSION AND CAROTID-SINUS BARORECEPTOR REFLEX IN RESTING MAN
by: Angelljames, J, et al.
Published: (1990)

Naloxone inhibits exercise-induced release of PRL and GH in athletes.
by: Moretti, C, et al.
Published: (1983)

The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone.
by: Grossman, A, et al.
Published: (1981)

Lack of effect of naloxone and schizophrenic auditory hallucinations.
by: Freeman, C, et al.
Published: (1981)

Are carfentanil and acrylfentanyl naloxone resistant?
by: Michael G. Feasel, et al.
Published: (2024-02-01)

Naloxone induced pulmonary edema
by: Sherif Elkattawy, et al.
Published: (2021-01-01)

ECT9 condensates with ECT1 and regulates plant immunity
by: Hui Wang, et al.
Published: (2023-04-01)

Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors
by: Michael Enich, et al.
Published: (2023-10-01)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
by: Christopher K. Blazes, et al.
Published: (2020-09-01)

Corticotropin-releasing hormone in health and disease: an update.
by: Ur, E, et al.
Published: (1992)

Cognitive effects after ECT: how to treat them?
by: E. Verwijk
Published: (2023-03-01)

Comparison of the Effect of Morphine Alone and with Naloxone on Testicular Morphology in Rats
by: Tahmineh Peirouvi, et al.
Published: (2019-11-01)

Rapid Absorption of Naloxone from Eye Drops
by: Johanna Tuunainen, et al.
Published: (2022-04-01)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
by: Joan Papp, et al.
Published: (2023-06-01)

The ECtHR’s Coping Strategy
by: Erik Voeten
Published: (2022-09-01)

Effect of Combining Ultralow-dose Naloxone with Morphine in Intravenous Patient-controlled Analgesia: The Cut-off Ratio of Naloxone to Morphine for Antiemesis After Gynecologic Surgery
by: Yu-Chang Yeh, et al.
Published: (2008-06-01)

Managing ECT related cognitive side effects: An individual approach
by: E. Verwijk
Published: (2021-04-01)

Influence of Shielding Arrangement on ECT Sensors
by: J. L. Fernandez Marron, et al.
Published: (2006-09-01)

A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs
by: Hawraa Sameer Sajwani, et al.
Published: (2022-10-01)

Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid
by: John C Messinger, et al.
Published: (2022-09-01)

Effectiveness of take ACTION online naloxone training for law enforcement officers
by: Chin Hwa Dahlem, et al.
Published: (2023-11-01)

Bystander preference for naloxone products: a field experiment
by: Katherine R. Marks, et al.
Published: (2023-11-01)

Promises and perils of the FDA's over-the-counter naloxone reclassification
by: David T. Zhu, et al.
Published: (2023-07-01)

m6A readers ECT2/ECT3/ECT4 enhance mRNA stability through direct recruitment of the poly(A) binding proteins in Arabidopsis
by: Peizhe Song, et al.
Published: (2023-04-01)

Correction to: Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
by: Kathryn G. Tippey, et al.
Published: (2019-05-01)

The use of ECT and MST in treating depression.
by: Allan, C, et al.
Published: (2011)

Catatonia, Pregnancy, and Electroconvulsive Therapy (ECT)
by: Khushbu Gandhi, et al.
Published: (2023-01-01)

Facilitating practical knowledge by using ECT
by: Rita Jentoft
Published: (2009-11-01)

ECtHR: Chocholáč v. Slovakia
by: Andrej Beleš
Published: (2022-12-01)